U.S. Markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.05
    +0.41 (+0.90%)
     
  • Gold

    1,842.10
    +1.00 (+0.05%)
     
  • Silver

    24.31
    +0.17 (+0.70%)
     
  • EUR/USD

    1.2120
    -0.0029 (-0.2424%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • Vix

    20.79
    -0.49 (-2.30%)
     
  • GBP/USD

    1.3427
    -0.0025 (-0.1880%)
     
  • USD/JPY

    104.1890
    +0.3290 (+0.3168%)
     
  • BTC-USD

    18,865.40
    -92.62 (-0.49%)
     
  • CMC Crypto 200

    369.55
    -9.69 (-2.56%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Novavax: 3Q Earnings Snapshot

·1 min read

GAITHERSBURG, Md. (AP) _ Novavax Inc. (NVAX) on Monday reported a loss of $197.3 million in its third quarter.

The Gaithersburg, Maryland-based company said it had a loss of $3.21 per share.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $2.36 per share.

The vaccine maker posted revenue of $157 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $234.2 million.

Novavax shares have climbed twenty-twofold since the beginning of the year. In the final minutes of trading on Monday, shares hit $90.31, increasing twentyfold in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVAX at https://www.zacks.com/ap/NVAX